Qingwang Han

Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia

Quanshun Wang, Yao Wang, Haiyan Lv et al. · Molecular Therapy · 2014 · 403 citations · Full text

CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma

Bo Guo, Meixia Chen, Qingwang Han et al. · Journal of Cellular Immunotherapy · 2015 · 201 citations · Full text

Cell Therapy, Immunology, Immune Cell Therapy +19

Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells

Yao Wang, Wenying Zhang, Qingwang Han et al. · Clinical Immunology · 2014 · 190 citations

Lymphoid Neoplasia, Delayed Toxicities, Effective Response +8

Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors

Bing Yu, Zhiying He, Pu You et al. · Cell stem cell · 2013 · 173 citations

Defined Factors, Induced Pluripotent Stem Cell, Developmental Biology +7

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

Hanren Dai, Wenying Zhang, Xiaolei Li et al. · OncoImmunology · 2015 · 164 citations · Full text